Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers

CompletedOBSERVATIONAL
Enrollment

344

Participants

Timeline

Start Date

July 11, 2023

Primary Completion Date

July 2, 2024

Study Completion Date

July 2, 2024

Conditions
Respiratory Syncytial Virus Infections
Trial Locations (15)

114

Investigational Site Number : 2880001, Navrongo

200

Investigational Site Number : 2880002, Kintampo

10400

Investigational Site Number : 7640001, Ratchathewi

11101

Investigational Site Number : 3400001, Tegucigalpa

21104

Investigational Site Number : 3400002, San Pedro Sula

28938

Investigational Site Number : 7240001, Móstoles

33100

Investigational Site Number : 2460003, Tampere

67100

Investigational Site Number : 2460004, Kokkola

90110

Investigational Site Number : 7640002, Songkhla

412216

Investigational Site Number : 3560002, Pune

570004

Investigational Site Number : 3560001, Mysuru

68114-3755

Quality Clinical Research - 10040 Regency Cir - HyperCore - PPDS Site Number : 8400001, Omaha

44121-4243

Senders Pediatrics Site Number : 8400002, Cleveland

00100

Investigational Site Number : 2460002, Helsinki

04400

Investigational Site Number : 2460001, Järvenpää

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY